A novel regimen for poor-prognosis or relapsed germ cell tumors

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2007年 / 4卷 / 11期
关键词：
D O I：
10.1038/ncponc0947x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：583 / 583
相关论文
共 50 条
  • [1] A novel treatment regimen for poor-prognosis or relapsed germ-cell tumors
    不详
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 620 - 621
  • [2] A novel treatment regimen for poor-prognosis or relapsed germ-cell tumors
    Nature Clinical Practice Oncology, 2007, 4 : 620 - 621
  • [3] The challenge of poor-prognosis germ cell tumors
    Toner, Guy C.
    UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (02) : 187 - +
  • [4] Management of poor-prognosis testicular germ cell tumors
    Khurana, Kiranpreet
    Gilligan, Timothy D.
    Stephenson, Andrew J.
    INDIAN JOURNAL OF UROLOGY, 2010, 26 (01) : 108 - 114
  • [5] Management of poor-prognosis or relapsed germ-cell cancer
    Daugaard, Gedske
    BJU INTERNATIONAL, 2009, 104 (9B) : 1392 - 1397
  • [6] ACCELERATED CHEMOTHERAPY FOR POOR-PROGNOSIS GERM-CELL TUMORS
    HORWICH, A
    DEARNALEY, DP
    NORMAN, A
    NICOLLS, J
    HENDRY, WF
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (11) : 1607 - 1611
  • [7] BOMP/EPI intensive chemotherapy in poor-prognosis Germ Cell Tumors (GCT)
    Tabernero, JM
    delMuro, XG
    Alba, E
    Sanchez, M
    Aparicio, J
    Barnadas, A
    Montesinos, J
    Martinez, M
    Germa, JR
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 161 - 161
  • [8] IDENTIFICATION AND MANAGEMENT OF POOR-PROGNOSIS GERM-CELL TUMORS - A NEED FOR CONSENSUS
    MEAD, GM
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) : 2217 - 2218
  • [9] INTENSIVE CHEMOTHERAPY IN POOR-PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
    LLUCH, JRG
    PALMER, MAS
    DURAN, MAC
    GUERRERO, RB
    SAGARRA, AF
    VILLAVICENCIO, H
    BALCELLS, FJS
    EUROPEAN UROLOGY, 1992, 21 (04) : 287 - 293
  • [10] Poor-prognosis germ cell tumors: We have not yet crossed the finish line
    Vaughn, David J.
    Stadtmauer, Edward A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 239 - 240
12345